Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

KIT's role in skin cells is not entirely independent, as other cells can influence its function.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

Microbeam Radiation Therapy is effective, but using a linear accelerator reduces its benefits.

New mutations in KRT83 and KRT86 are linked to the hair disorder monilethrix.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

TB and BCC tumors show similar follicular differentiation patterns.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

The PCR technique can identify genetic differences in a wool-related gene among different sheep breeds, which may help improve wool and pelt quality.

A gene mutation causes curly hair and hair loss in rats.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

rTMS may help treat trichotillomania in some patients.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Testosterone reduces knee movement, while flutamide and finasteride increase it.